www.fdanews.com/articles/206551-medmira-gets-ce-mark-for-its-revealcovid-19-plus-total-antibody-test
MedMira Gets CE Mark for Its REVEALCOVID-19 PLUS Total Antibody Test
February 11, 2022
Nova Scotia, Canada-based MedMira has received a CE mark certification for its REVEALCOVID-19 PLUS Total Antibody Test.
The blood test, which detects the presence of antibodies against the SARS-CoV-2 virus generated by either a previous infection or vaccination, can be completed in less than three minutes, from the moment the blood is drawn until the test provides a result.
MedMira offers its tests in a single pack for individual use and in bulk packaging for standard screening. The test will be available in Europe and any countries accepting the CE mark, the company said.